Lassau N - Search Results

1

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.

Naccache R, Belkouchi Y, Lawrance L, Benatsou B, Hadchiti J, Cournede PH, Ammari S, Talbot H, Lassau N. Naccache R, et al. Among authors: lassau n. Cancers (Basel). 2022 Mar 4;14(5):1337. doi: 10.3390/cancers14051337. Cancers (Basel). 2022. PMID: 35267645 Free PMC article.

2

Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment.

Lassau N, Chami L, Benatsou B, Peronneau P, Roche A. Lassau N, et al. Eur Radiol. 2007 Dec;17 Suppl 6:F89-98. doi: 10.1007/s10406-007-0233-6. Eur Radiol. 2007. PMID: 18376462 Review.

3

[Evaluation of early response to antiangiogenic treatment with dynamic contrast enhanced ultrasound].

Lassau N, Brule A, Chami L, Benatsou B, Péronneau P, Roche A. Lassau N, et al. J Radiol. 2008 May;89(5 Pt 1):549-55. doi: 10.1016/s0221-0363(08)71480-x. J Radiol. 2008. PMID: 18535495 Review. French.

4

[Targeted treatments: which imaging?].

Lassau N, Chebil M, Benatsou B, Chami L, Roche A. Lassau N, et al. Bull Cancer. 2008 Oct;95(10):989-93. doi: 10.1684/bdc.2008.0721. Bull Cancer. 2008. PMID: 19004731 French.

5

Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography.

Lassau N, Koscielny S, Albiges L, Chami L, Benatsou B, Chebil M, Roche A, Escudier BJ. Lassau N, et al. Clin Cancer Res. 2010 Feb 15;16(4):1216-25. doi: 10.1158/1078-0432.CCR-09-2175. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145174

6

Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Leguerney I, Lassau N, Koscielny S, Rodrigues M, Massard C, Rouffiac V, Benatsou B, Thalmensi J, Bawa O, Opolon P, Peronneau P, Roche A. Leguerney I, et al. Among authors: lassau n. Invest New Drugs. 2012 Feb;30(1):144-56. doi: 10.1007/s10637-010-9543-y. Epub 2010 Oct 6. Invest New Drugs. 2012. PMID: 20924644

7

Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.

Lassau N, Koscielny S, Chami L, Chebil M, Benatsou B, Roche A, Ducreux M, Malka D, Boige V. Lassau N, et al. Radiology. 2011 Jan;258(1):291-300. doi: 10.1148/radiol.10091870. Epub 2010 Oct 27. Radiology. 2011. PMID: 20980447 Clinical Trial.

8

Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.

Lassau N, Chami L, Koscielny S, Chebil M, Massard C, Benatsou B, Bidault S, Cioffi A, Blay JY, Le Cesne A. Lassau N, et al. Invest New Drugs. 2012 Apr;30(2):765-71. doi: 10.1007/s10637-010-9592-2. Epub 2010 Dec 7. Invest New Drugs. 2012. PMID: 21136137 Clinical Trial.

9

Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments.

Lassau N, Chami L, Chebil M, Benatsou B, Bidault S, Girard E, Abboud G, Roche A. Lassau N, et al. Discov Med. 2011 Jan;11(56):18-24. Discov Med. 2011. PMID: 21276407 Free article.

10

Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.

Lassau N, Chapotot L, Benatsou B, Vilgrain V, Kind M, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Uzan-Augui J, Koscielny S. Lassau N, et al. Invest Radiol. 2012 Dec;47(12):711-6. doi: 10.1097/RLI.0b013e31826dc255. Invest Radiol. 2012. PMID: 23095862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters